Learn
Patient Navigation Program
Expanded Access Programs
Brain Tumor Symptoms
Guide For High Grade Tumors
Guide For Low Grade Tumors
Checklist For Newly Diagnosed
Video Library
Noteworthy Treatments & Tips
Brain Tumor News
Survivor Stories
Fundraising
DC-Vax
Modeyso™(Onc-201) for DIPG/DMG
Optune
Temodar (Temozolomide)
GammaTile
Newsletter
Subscribe
Change Email
Unsubscribe
Archives
Virtual Trial
What is it?
Join
Submit An Update
Map of Participants
Resources
Copayment Assistance Program
Drug Discount Card
Clinical Trial Search
Brain Tumor Centers
Support Groups
Links To Other Resources
Books
Memorials
About Us
Musella Foundation
Research Grants
Recent Additions To Website
Privacy Policy
Ethics And Values
Our Sponsors
Financials
Contact
donations
Sponsored by
Please click on the above banner for more details
Brain Tumor News
Brain Tumor Conferences / Events
Brain Tumor News!
Subscribe to our Free Brain Tumor News Blast E-Mail Newsletter
Brain Tumor News Blast Archives
Submit a press release or abstract
Recent additions to this website!
Brain Tumor News!
Note: The comments under each article title are the
opinion
of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 3530 to 3549 of 7,806
Previous 20
Next 20
10/04/08
A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).
10/04/08
Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.
10/04/08
Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM).
10/04/08
Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas.
10/04/08
Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.
10/04/08
A retrospective single institutional analysis of bevacizumab and chemotherapy versus non-bevacizumab treatments for recurrent glioblastoma.
10/04/08
Patterns of relapse and prognosis after bevacizumab (BEV) failure in recurrent glioblastoma (GBM).
10/04/08
NY Islanders Fundraiser for Brain Tumor Research
10/03/08
TMZ-BioShuttle - a reformulated Temozolomide.
10/03/08
Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.
10/03/08
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children's Oncology Group.
10/03/08
Radiosurgery and carcinogenesis risk.
10/03/08
Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas.
10/03/08
Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.
10/03/08
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
09/30/08
Radiosurgery for brain cancer OK for elderly
09/30/08
Maureen’s Autumn Days Calendar Raffle - to benefit brain cancer patients who need financial assistance
09/29/08
Dosing Initiated in TransMolecular’s Phase 1/2 Clinical Trial for Intravenous Administration of 131Iodine-TM601 in Patients with Recurrent Malignant Glioma
09/28/08
Cell Phone Use and Tumors: What the Science Says
09/28/08
Temozolomide Not Superior to Procarbazine-Based Combination Treatment in Patients With High-Grade Glioma: Presented at ESMO
Displaying Stories 3530 to 3549 of 7806
Previous 20
Next 20
Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!